Indication, organization, practical implementation and interpretation guidelines for retrospective CGM recording: A French position statement

Diabetes and Metabolism

Volumn 41, Issue 6, 2015, Pages 498-508

  Joubert, M ^a   Baillot Rudoni, S ^b   Catargi, B ^c   Charpentier, G ^d   Esvant, A ^e   Franc, S ^d   Guerci, B ^f   Guilhem, I ^e   Melki, V ^g   Merlen, E ^h   Penfornis, A ^d   Renard, E ⁱ   Riveline, J P ^j   Schaepelynck, P ^k   Sola Gazagnes, A ^l   Hanaire, H ^g  

^a CAEN UNIVERSITY HOSPITAL   (France)

^b DIJON UNIVERSITY HOSPITAL   (France)

^c BORDEAUX UNIVERSITY HOSPITAL   (France)

^d CENTRE HOSPITALIER SUD FRANCILIEN   (France)

^e RENNES UNIVERSITY HOSPITAL   (France)

^f UNIVERSITY HOSPITAL OF NANCY   (France)

^g TOULOUSE UNIVERSITY HOSPITAL   (France)

^h LILLE UNIVERSITY HOSPITAL   (France)

ⁱ MONTPELLIER UNIVERSITY HOSPITAL   (France)

^j HÔPITAL LARIBOISIÈRE   (France)

^k ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^l Cochin Hospital ^*  (France)

more..

Author keywords

Diabetes; Glucose profile; Position statement; Retrospective CGM; Self monitoring of blood glucose

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; GLUCOSE BLOOD LEVEL;

ARTICLE; BLOOD GLUCOSE MONITORING; CONTINUOUS GLUCOSE MONITORING; DIABETES MELLITUS; PHYSICIAN; PRACTICE GUIDELINE; RETROSPECTIVE STUDY; ANALYSIS; GLUCOSE BLOOD LEVEL; HUMAN;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS; HUMANS;

EID: 84938790725     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2015.07.001     Document Type: Article

References (37)

1. Tubiana-Rufi N, Riveline JP, Dardari D. Real-time continuous glucose monitoring using GuardianRT: from research to clinical practice. Diabetes Metab 2007;33:415-20.
2. Benhamou PY, Catargi B, Delenne B, Guerci B, Hanaire H, Jeandidier N, et al. Real-time continuous glucose monitoring (CGM) integrated into the treatment of type 1 diabetes: consensus of experts from SFD, EVADIAC and SFE. Diabetes Metab 2012;38:S67-83.
3. Groupe de travail HAS. Holter glycémique: mesure ambulatoire de la glycémie en continu (CGMS); 2006 www.has-sante.fr
4. Bergenstal RM, Ahmann AJ, Bailey T, Beck RW, Bissen J, Buckingham B, et al. Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP). Diabetes Technol Ther 2013;15:198-211.
5. Miele A, Weiland K, Dungan KM. Clinical outcomes associated with referral-based continuous glucose monitoring using a central standardized interpretation strategy. Diabetes Technol Ther 2012;14:765-71.
6. Chase HP, KimLM, Owen SL, MacKenzie TA, Klingensmith GJ, Murtfeldt R, et al. Continuous subcutaneous glucose monitoring in children with type 1 diabetes. Pediatrics 2001;107:222-6.
7. Ludvigsson J, Hanas R. Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled crossover study. Pediatrics 2003;111:933-8.
8. Yates K, Hasnat Milton A, Dear K, Ambler G. Continuous glucose monitoring-guided insulin adjustment in children and adolescents on nearphysiological insulin regimens: a randomized controlled trial. Diabetes Care 2006;29:1512-7.
9. Lagarde WH, Barrows FP, Davenport ML, Kang M, Guess HA, Calikoglu AS. Continuous subcutaneous glucose monitoring in children with type 1 diabetes mellitus: a single-blind, randomized, controlled trial. Pediatr Diabetes 2006;7:159-64.
10. Deiss D, Hartmann R, Schmidt J, Kordonouri O. Results of a randomised controlled cross-over trial on the effect of continuous subcutaneous glucose monitoring (CGMS) on glycaemic control in children and adolescents with type 1 diabetes. Exp Clin Endocrinol Diabetes 2006;114:63-7.
11. Chico A, Vidal-Ríos P, Subirà M, Novials A. The continuous glucose monitoring system is useful for detecting unrecognized hypoglycaemias in patients with type 1 and type 2 diabetes but is not better than frequent capillary glucose measurements for improving metabolic control. Diabetes Care 2003;26:1153-7.
12. Tanenberg R, Bode B, Lane W, Levetan C, Mestman J, Harmel AP, et al. Use of the Continuous Glucose Monitoring System to guide therapy in patients with insulin-treated diabetes: a randomized controlled trial. Mayo Clin Proc 2004;79:1521-6.
13. Cooke D, Hurel SJ, Casbard A, Steed L, Walker S, Meredith S, et al. Randomized controlled trial to assess the impact of continuous glucose monitoring on HbA(1c) in insulin-treated diabetes (MITRE Study). Diabet Med 2009;26:540-7.
14. Boland E, Monsod T, Delucia M, Brandt CA, Fernando S, Tamborlane. Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Diabetes Care 2001;24:1858-62.
15. Gandrud LM, Xing D, Kollman C, Block JM, Kunselman B, Wilson DM, et al. The Medtronic Minimed Gold continuous glucose monitoring system: an effective means to discover hypo-and hyperglycaemia in children under 7 years of age. Diabetes Technol Ther 2007;9:307-16.
16. Schaepelynck-Bélicar P, Vague P, Simonin G, Lassmann-Vague V Improved metabolic control in diabetic adolescents using the continuous glucose monitoring system (CGMS). Diabetes Metab 2003;29:608-12.
17. Hay LC, Wilmshurst EG, Fulcher G. Unrecognized hypo-and hyperglycaemia in well-controlled patients with type 2 diabetes mellitus: the results of continuous glucose monitoring. Diabetes Technol Ther 2003;5:19-26.
18. Choudhary P, Davies C, Emery CJ, Heller SR. Do high fasting glucose levels suggest nocturnal hypoglycaemia? The Somogyi effect-more fiction than fact? Diabet Med 2013;30:914-7.
19. Schiaffini R, Ciampalini P, Fierabracci A, Spera S, Borrelli P, et al. The Continuous Glucose Monitoring System (CGMS) in type 1 diabetic children is the way to reduce hypoglycaemic risk. Diabetes Metab Res Rev 2002;18:324-9.
20. Amin R, Ross K, Acerini CL, Edge JA, Warner J, Dunger DB. Hypoglycaemia prevalence in prepubertal children with type 1 diabetes on standard insulin regimen: use of continuous glucose monitoring system. Diabetes Care 2003;26:662-7.
21. Wiltshire EJ, Newton K, McTavish L. Unrecognised hypoglycaemia in children and adolescents with type 1 diabetes using the continuous glucose monitoring system: prevalence and contributors. J Paediatr Child Health 2006;42:758-63.
22. DesouzaC, Salazar H, Cheong B, Murgo J, Fonseca V. Association of hypoglycaemia and cardiac ischemia: a study based on continuous monitoring. Diabetes Care 2003;26:1485-9.
23. KaufmanFR, GibsonLC, HalvorsonM, CarpenterS,FisherLK, Pitukcheewanont P. A pilot study of the continuous glucose monitoring system: clinical decisions and glycaemic control after its use in pediatric type 1 diabetic subjects. Diabetes Care 2001;24:2030-4.
24. Cheyne EH, Cavan DA, Kerr D. Performance of a continuous glucose monitoring system during controlled hypoglycaemia in healthy volunteers. Diabetes Technol Ther 2002;4:607-13.
25. Monsod TP, Flanagan DE, Rife F, Saenz R, Caprio S, Sherwin RS, et al. Do sensor glucose levels accurately predict plasma glucose concentrations during hypoglycaemia and hyperinsulinemia? Diabetes Care 2002;25:889-93.
26. Aussedat B, Dupire-Angel M, Gifford R, Klein JC, Wilson GS, Reach G Interstitial glucose concentration and glycaemia: implications for continuous subcutaneous glucose monitoring. Am J Physiol Endocrinol Metab 2000;278:E716-28.
27. McGowan K, Thomas W, Moran A. Spurious reporting of nocturnal hypoglycaemia by CGMS in patients with tightly controlled type 1 diabetes. Diabetes Care 2002;25:1499-503.
28. Mensh BD, Wisniewski NA, Neil BM, Burnett DR. Susceptibility of interstitial continuous glucose monitor performance to sleeping position. J Diabetes Sci Technol 2013;7:863-70.
29. Franc S, Dardari D, Boucherie B, Riveline JP, Biedzinski M, Petit C, et al. Real-life application and validation of flexible intensive insulintherapy algorithms in type 1 diabetes patients. Diabetes Metab 2009;35: 463-8.
30. Murphy HR, Rayman G, Lewis K, Kelly S, Johal B, Duffield K, et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ 2008;337:a1680.
31. Rodríguez-Segade S, Rodríguez J, García Lopez JM, Casanueva FF, Camiña F. Estimation of the glycation gap in diabetic patients with stable glycaemic control. Diabetes Care 2012;35:2447-50.
32. Cohen RM, Smith EP Frequency of HbA1c discordance in estimating blood glucose control. Curr Opin ClinNutr Metab Care 2008;11:512-7.
33. Riveline JP, Teynie J, Belmouaz S, Franc S, Dardari D, Bauwens M, et al. Glycaemic control in type 2 diabetic patients on chronic haemodialysis: use of a continuous glucose monitoring system. Nephrol Dial Transplant 2009;24:2866-71.
34. Hempe JM, Gomez R, McCarter Jr RJ, Chalew SA. High and low hemoglobin glycation phenotypes in type 1 diabetes: a challenge for interpretation of glycaemic control. J Diabetes Complications 2002;16: 313-20.
35. Joubert M, Fourmy C, Henri P, Ficheux M, Lobbedez T, Reznik Y. Effectiveness of continuous glucose monitoring in dialysis patients with diabetes: The DIALYDIAB pilot study. Diabetes Res Clin Pract 2015;107: 348-54.
36. Bragd J, Adamson U, BäcklundLB, Lins PE, Moberg E, Oskarsson P. Can glycaemic variability, as calculated from blood glucose self-monitoring, predict the development of complications in type 1 diabetes over a decade? Diabetes Metab 2008;34:612-6.
37. Soupal J1, Skrha Jr J, Fajmon M, Horová E, Mráz M, Skrha J, et al. Glycaemic variability is higher in type 1 diabetes patients with microvascular complications irrespective of glycaemic control. Diabetes Technol Ther 2014;16:198-203.